SCHEMBL11197459

SCHEMBL11197459

[CH2]COc1ccc(C(=O)N(C)C)cc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.63
▸ HPGD P15428 1/20 0.63
▸ MAOB P27338 1/20 0.54
▸ AOC3 Q16853 1/20 0.54
▸ TBXAS1 P24557 1/20 0.50
▸ DRD2 P14416 1/20 0.44
▸ GPR119 Q8TDV5 6/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ EGFR P00533 1/20 0.44
▸ MAPT P10636 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ PARP10 Q53GL7 1/20 0.42
▸ GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9388919 0.83 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2HPGDMAOBAOC3
SCHEMBL578734 0.80 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2HPGDMAOBAOC3
SCHEMBL10932269 0.80 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2HPGDTBXAS1L3MBTL1
SCHEMBL10460818 0.79 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2HPGDMAOBAOC3
SCHEMBL26681150 0.79 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2HPGDMAOBAOC3
SCHEMBL10754241 0.79 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2HPGDMAOBAOC3
SCHEMBL2535516 0.79 HPGD (0.70) ALDH1A1SMN1; SMN2HPGDMAOBAOC3
SCHEMBL7042102 0.79 L3MBTL1 (0.68) ALDH1A1SMN1; SMN2HPGDMAOBMAPT
Hydrochloric Acid SCHEMBL12503056 0.77 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2HPGDMAOBAOC3
SCHEMBL7637707 0.77 TP53 (0.66) ALDH1A1SMN1; SMN2HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4391980-A FOR INVERSION OF CONFIGURATION OF OPTICALLY ACTIVE COMPOUNDS CIBA-GEIGY CORPORATION (US) 1983-07-05 — — US disclosed
EP-0007605-B1 A PROCESS FOR INVERTING THE CONFIGURATION IN OPTICALLY ACTIVE COMPOUNDS AND OPTICALLY ACTIVE INTERMEDIATE COMPOUNDS AND THEIR SALTS REQUIRED THEREFOR CIBA-GEIGY AG (CH) 1982-09-15 — — EP disclosed
US-4294966-A SALT FORMATION CIBA-GEIGY CORPORATION (US) 1981-10-13 — — US disclosed
EP-0007605-A1 A process for inverting the configuration in optically active compounds and optically active intermediate compounds and their salts required therefor CIBA-GEIGY AG (CH) 1980-02-06 — — EP disclosed
US-4161530-A CYCLIC SUBSTITUTED AMINO ALCOHOL BETA-RECEPTOR-BLOCKING AGENT AND TRYPTOPHANE CIBA-GEIGY CORPORATION (US) 1979-07-17 — — US disclosed
Send feedback